Abstract
• Background
Orbital lymphoid hyperplasia can be associated with systemic non-Hodgkin lymphoma (NHL), even when polyclonal proliferation is found in the orbit. Although irradiation is recommended, some orbital lymphoid hyperplasias are treated by steroids (when inflammation is clinically presumed) or left untreated.
• Methods
The incidence of concurrent NHL and the incidence of future NHL after oral prednisone, radiotherapy, or no treatment were retrospectively evaluated in 33 cases of lymphoid hyperplasia (22 benign lymphoid hyperplasias, BLH, and 11 atypical lymphoid hyperplasias, ALH), after follow-up of 2–13 years.
• Results
NHL occurred in 12 of 33 cases (36.4%). In seven patients it was concurrent; in five patients it occurred 2–6 years later. In the actuarial curve, at 5 years 55% of patients were free of lymphoma, at 10 years, 46%. NHL was more commonly observed when the lacrimal gland was involved (57% vs 21%; P=0.03). Of the 13 patients treated with oral steroids, 46% had complete response, 39% partial response, and 15% future NHL. Of the seven irradiated patients, five (71%) had complete response, two (29%) partial response, and none future NHL. Of the eight untreated patients, five (63%) had partial response and three (37%) future NHL. Irradiated lacrimal gland BLHs only achieved partial response, one having radiation-induced orbital inflammation.
• Conclusion
Because of a high risk of NHL, in all orbital lymphoid tumors systemic staging and follow-up are mandatory. The advised management is irradiation, except for Sjögren syndrome, an initially inflammatory lacrimal gland BLH, where a course of steroid is suggested before considering radiotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Azzpardi JG, Evans DJ (1971) Malignant lymphoma of parotid associated with Mikulicz disease (benign lymphoepithelial lesion). J Clin Pathol 24:744–752
Dhermy P, Diebold J, Tricot G, Offret G (1981) Le lymphome malin lymphoplasmocytaire de l'orbite et de la conjonctive. J Fr Ophthalmol 4:553–563
Finkelstein M, Jakobiec FA (1994) Laboratory evaluation of ocular and adnexal lymphoid lesions. Int Ophthalmol Clin 34:283–292
Font RL, Laucirica R, Rosenbaum PS, Patrinely JR, Boniuk M (1992) Malignant lymphoma of the ocular adnexa associated with the benign lymphoepithelial lesion of the parotid glands. Report of two cases. Ophthalmology 99:1582–1587
Garner A (1992) Orbital lymphoproliferative disorders. Br J Ophthalmol 76:47–48
Jakobiec FA, Knowles DM II (1989) An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc 87:420–442
Jakobiec FA, Neri A, Knowles DM II (1987) Genotypic monoclonality in immunophenotypically polyclonal orbital lymphoid tumors. A model of tumor progression in the lymphoid system. Ophthalmology 94:980–994
Jakobiec FA, Yeo JH, Trokel SL, Abbott GF, Anderson R, Citrin CM, Alper MG (1982) Combined clinical and computed tomographic diagnosis of primary lacrimal fossa lesions. Am J Ophthalmol 94:785–807
Kaplan EL, Meier P (1958) Non-parametric evaluation from incomplete observation. J Am Star Assoc 53:457–458
Kassan SS, Thomas TL, Moutsopoulos HM, et al. (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:882–892
Kennerdell JS, Dresner SC (1984) The nonspecific orbital inflammatory syndromes. Surv Ophthalmol 29:93–103
Knowles DM II, Jakobiec FA (1980) Orbital lymphoid neoplasms. A clinicopathologic study of 60 patients. Cancer 46:576–589
Knowles DM II, Jakobiec FA, McNally L, Burke JS (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids). A prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 21:959–973
Mauriello JA, Flanagan JC (1989) Pseudotumor and lymphoid tumor: distinct clinicopathologic entities. Surv Ophthalmol 34:142–148
Peto R, Pike MC, Armitage P, et al. (1977) Randomised clinical trials requiring prolonged observation in each patient. II. Analysis and examples. Br J Cancer 35:1–39
Platanias LC, Putterman AM, Vijayakumar S, Recant W, Weichselbaum RR, Bitran J (1992) Treatment and prognosis of orbital non-Hodgkin lymphomas. Am J Clin Oncol 15:79–83
Polito E, Leccisotti A (1993) Epithelial malignancies of the lacrimal gland: survival rates after extensive and conservative therapy. Ann Ophthalmol 25:422–426
Polito E, Leccisotti A (1994) CT and MRI features of lacrimal fossa tumors. A retrospective study of 72 cases. Orbit 13:25–38
Rootman J, Nugent R (1982) The classification and management of acute orbital pseudotumors. Ophthalmology 89:1040–1048
Schmid U, Helbron D, Lennert K (1982) Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome). Virchows Arch Pathol Anat 395:11–43
The Non-Hodgkin's Lymphoma Classification Project (1982) National Cancer Institute sponsored study of classifications of NHL. Summary and description of a working formulation for clinical usage. Cancer 49:2112–2135
Turner RR, Egbert P, Warnke RA (1984) Lymphocytic infiltrates of the conjunctiva and orbit: immunohistochemical staining of 16 cases. Am J Clin Pathol 81:447–452
Wan JH, Trainor KJ, Brisco MJ, Morley AA (1990) Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 43:888–890
Westacott S, Garner A, Moseley IF, Wright JE (1991) Orbital lymphoma versus reactive lymphoid hyperplasia: an analysis of the use of computed tomography in differential diagnosis. Br J Ophthalmol 75:722–725
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Polito, E., Leccisotti, A. Prognosis of orbital lymphoid hyperplasia. Graefe's Arch Clin Exp Ophthalmol 234, 150–154 (1996). https://doi.org/10.1007/BF00462026
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00462026